Michael Milburn, based in Apex, NC, US, is currently a CEO and President at GeneCentric Therapeutics, Inc., bringing experience from previous roles at GeneCentric Therapeutics, Inc., Metabolon, Sirtris Pharmaceuticals and Plexxikon Inc.. Michael Milburn holds a 1992 - 1994 Post-Doc Research in Nuclear Hormone Receptors @ Harvard Medical School. With a robust skill set that includes Organic Chemistry, Molecular Biology, Biochemistry, Cancer, Protein Chemistry and more, Michael Milburn contributes valuable insights to the industry. Michael Milburn has 4 emails on RocketReach.